Join the Crohn's Disease group to help and get support from people like you.
Crohn's Disease News
Related terms: Crohns
Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
THURSDAY, July 24, 2025 – Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately to severely active Crohn disease, according to...
Digital Model Based on Noninvasive Factors Shows Accuracy for Identifying IBD in Children
TUESDAY, July 22, 2025 – A model based on noninvasive tests shows high accuracy as a digital tool for the rapid identification of children with inflammatory bowel disease (IBD), according to a study...
Healthy Plant-Based Diet May Lower Inflammatory Bowel Disease Risk
WEDNESDAY, July 16, 2025 – A healthy plant-based diet may reduce the risk for inflammatory bowel disease (IBD) due to the anti-inflammatory properties of the diet, according to a study published...
Increase in Chronic Digestive Disorders Seen During Pandemic
WEDNESDAY, July 9, 2025 – There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study recently...
Inflammatory Activity With IBD Tied to Impaired Sleep
WEDNESDAY, July 9, 2025 – Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms, according to a study published online June 26 in Clinical ...
Fruits And Veggies Protective Against IBD, Study Says
WEDNESDAY, July 9, 2025 — A healthy plant-based diet might protect people from inflammatory bowel diseases, a new study says. People noshing healthy plant-based foods had a 14% lower risk of Crohn’s d...
Common Meds Aren't Linked To Inflammatory Bowel Disease, Study Says
TUESDAY, July 8, 2025 — There’s no evidence that common medications can trigger a chronic inflammatory bowel disease called microscopic colitis, a new study says. Microscopic colitis is responsible fo...
Most TikTok Videos on Inflammatory Bowel Disease Are Low Quality
FRIDAY, June 13, 2025 -- The most-viewed inflammatory bowel disease (IBD) videos on TikTok provide low-quality medical information, according to a study published online in the May/June issue ...
Inflammatory Bowel Disease Info Lacking On TikTok
WEDNESDAY, June 11, 2025 — Many folks with inflammatory bowel disease (IBD) are turning to TikTok for advice, but they aren’t likely to receive useful and accurate information, a new study says. Ana...
FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara
Guangzhou and London – May 27, 2025 – Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharm...
Spatiotemporal Mapping IDs Four Stages of Inflammatory Bowel Disease Evolution
TUESDAY, May 6, 2025 – Machine learning has enabled spatiotemporal mapping of the four stages of the evolution of inflammatory bowel disease (IBD), according to a study published online April 30...
Monthly News Roundup - March 2025
FDA Approves Tremfya for Adults Patients with Active Crohn’s Disease In March, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (guselkumab) for the t...
FDA Approves Tremfya for Active Crohn Disease in Adults
MONDAY, March 24, 2025 – The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease. This approval is the fourth...
Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD
MONDAY, March 24, 2025 – Among people with inflammatory bowel disease (IBD), conditions developed at or before age 60 years and their age of onset are important for predicting premature death,...
FDA Approves Tremfya (guselkumab) for Adult Patients with Moderately to Severely Active Crohn’s Disease
HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab), the first and only IL-23 inhibitor o...
Further information
Related condition support groups
Crohn's Disease - Maintenance, Crohn's Disease - Acute, Inflammatory Bowel Disease
Related drug support groups
Humira, Entyvio, Stelara, Remicade, Skyrizi, cholestyramine, adalimumab, budesonide, ustekinumab, Cimzia, Tremfya